Marksans Pharma’s arm receives marketing authorization for Baclofen

19 Mar 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary in UK -- Relonchem has received Marketing Authorization for the product Baclofen 10 mg Tablets from UK Medicines and Healthcare Products Regulatory Agency (UK MHRA). 

Earlier, Relonchem had received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.


Marksans Pharma Share Price

221.70 -0.65 (-0.29%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...